200,000+ products from a single source!

sales@angenechem.com

Home > Quinoline > 105628-72-6

105628-72-6

105628-72-6 | 1-[(1,2-DIHYDRO-1-OXO-5-ISOQUINOLINYL)SULFONYL]HEXAHYDRO-1H-1,4-DIAZEPINE

CAS No: 105628-72-6 Catalog No: AG008RE1 MDL No:MFCD01752417

Product Description

Catalog Number:
AG008RE1
Chemical Name:
1-[(1,2-DIHYDRO-1-OXO-5-ISOQUINOLINYL)SULFONYL]HEXAHYDRO-1H-1,4-DIAZEPINE
CAS Number:
105628-72-6
Molecular Formula:
C14H17N3O3S
Molecular Weight:
307.3681
MDL Number:
MFCD01752417
IUPAC Name:
5-(1,4-diazepan-1-ylsulfonyl)-2H-isoquinolin-1-one
InChI:
InChI=1S/C14H17N3O3S/c18-14-12-3-1-4-13(11(12)5-7-16-14)21(19,20)17-9-2-6-15-8-10-17/h1,3-5,7,15H,2,6,8-10H2,(H,16,18)
InChI Key:
ZAVGJDAFCZAWSZ-UHFFFAOYSA-N
SMILES:
O=c1[nH]ccc2c1cccc2S(=O)(=O)N1CCNCCC1

Properties

Complexity:
526  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
307.099g/mol
Formal Charge:
0
Heavy Atom Count:
21  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
307.368g/mol
Monoisotopic Mass:
307.099g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
86.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.2  

Literature

Title Journal
Hydroxyfasudil ameliorates penile dysfunction in the male spontaneously hypertensive rat. Pharmacological research 20121001
HIV-1 Tat-induced cerebrovascular toxicity is enhanced in mice with amyloid deposits. Neurobiology of aging 20120801
Evidence of a direct cellular protective effect of Rho-kinase inhibitors on endothelin-induced cardiac myocyte hypertrophy. Biochemical and biophysical research communications 20120727
Hydroxyfasudil ameliorates bladder dysfunction in male spontaneously hypertensive rats. Urology 20120501
Long-term treatment with nifedipine suppresses coronary hyperconstricting responses and inflammatory changes induced by paclitaxel-eluting stent in pigs in vivo: possible involvement of Rho-kinase pathway. European heart journal 20120301
Propofol neurotoxicity is mediated by p75 neurotrophin receptor activation. Anesthesiology 20120201
Inhibition of Rho kinase by hydroxyfasudil attenuates brain edema after subarachnoid hemorrhage in rats. Neurochemistry international 20120201
Antivasospastic effects of hydroxyfasudil, a Rho-kinase inhibitor, after subarachnoid hemorrhage. Journal of pharmacological sciences 20120101
High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: role of mitochondrial KATP channels. Cardiovascular diabetology 20120101
Protein phosphatase 1 dephosphorylates profilin-1 at Ser-137. PloS one 20120101
Pirfenidone inhibits transforming growth factor-β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19. Molecular vision 20120101
On the role of RhoA/ROCK signaling in contact guidance of bone-forming cells on anisotropic Ti6Al4V surfaces. Acta biomaterialia 20110401
Ca2+ sensitization and PKC contribute to exercise training-enhanced contractility in porcine collateral-dependent coronary arteries. American journal of physiology. Heart and circulatory physiology 20110401
Fasudil protects cultured N1E-115 cells against lysophosphatidic acid-induced neurite retraction through inhibition of Rho-kinase. Brain research bulletin 20110201
Fragment-based discovery of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors. Bioorganic & medicinal chemistry letters 20110101
Dynamic changes in neurexins' alternative splicing: role of Rho-associated protein kinases and relevance to memory formation. PloS one 20110101
Secrets of aging: What does a normally aging brain look like? F1000 biology reports 20110101
Hydroxyfasudil-mediated inhibition of ROCK1 and ROCK2 improves kidney function in rat renal acute ischemia-reperfusion injury. PloS one 20110101
ROCKing Regeneration: Rho Kinase Inhibition as Molecular Target for Neurorestoration. Frontiers in molecular neuroscience 20110101
Mutant huntingtin alters cell fate in response to microtubule depolymerization via the GEF-H1-RhoA-ERK pathway. The Journal of biological chemistry 20101126
Simultaneous quantitative analysis of fasudil and its active metabolite in human plasma by liquid chromatography electro-spray tandem mass spectrometry. Journal of pharmaceutical and biomedical analysis 20100605
Effects of sex and estrogen on chicken ductus arteriosus reactivity. American journal of physiology. Regulatory, integrative and comparative physiology 20100501
Role of Rho-kinase in mediating contraction of chicken embryo femoral arteries. Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology 20100301
Abstracts of the 16th Annual Society on NeuroImmune Pharmacology (SNIP) Conference. April 13-17, 2010. Manhattan Beach, California, USA. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20100301
Hit to lead account of the discovery of bisbenzamide and related ureidobenzamide inhibitors of Rho kinase. Journal of medicinal chemistry 20100128
Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage. Brain research bulletin 20100115
Recent development of cyclic amide (pyridone/lactam) moiety containing heterocycles as protein kinase inhibitors. Current medicinal chemistry 20100101
Characterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotype. PloS one 20100101
The role of RhoA/Rho kinase pathway in endothelial dysfunction. Journal of cardiovascular disease research 20100101
Role of Rho-kinase in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in pigs in vivo. Journal of the American College of Cardiology 20091208
Maturation of O2 sensing and signaling in the chicken ductus arteriosus. American journal of physiology. Lung cellular and molecular physiology 20091001
Effect of the rho-kinase inhibitor hydroxyfasudil on bladder overactivity: an experimental rat model. International journal of urology : official journal of the Japanese Urological Association 20091001
Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension. Circulation journal : official journal of the Japanese Circulation Society 20090901
Simvastatin suppresses leptin expression in 3T3-L1 adipocytes via activation of the cyclic AMP-PKA pathway induced by inhibition of protein prenylation. Journal of biochemistry 20090601
Remote periconditioning reduces myocardial no-reflow by the activation of K ATP channel via inhibition of Rho-kinase. International journal of cardiology 20090403
A role for Rho-kinase in Ca-independent contractions induced by phorbol-12,13-dibutyrate. Clinical and experimental pharmacology & physiology 20090301
Morphological and functional alterations of the ductus arteriosus in a chicken model of hypoxia-induced fetal growth retardation. Pediatric research 20090301
Peripheral delivery of a ROCK inhibitor improves learning and working memory. Behavioral neuroscience 20090201
RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension. Vascular health and risk management 20090101
Dopamine D2 receptor stimulation potentiates PolyQ-Huntingtin-induced mouse striatal neuron dysfunctions via Rho/ROCK-II activation. PloS one 20090101
Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes. Biophysical journal 20081001
Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins. Diabetes 20081001
Rho kinase-dependent CCL20 induced by dynamic compression of human chondrocytes. Arthritis and rheumatism 20080901
Improvement of cognitive deficit and neuronal damage in rats with chronic cerebral ischemia via relative long-term inhibition of rho-kinase. Cellular and molecular neurobiology 20080801
Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study. Neurologia medico-chirurgica 20080601
The therapeutic effects of Rho-ROCK inhibitors on CNS disorders. Therapeutics and clinical risk management 20080601
Wide therapeutic time window for Rho-kinase inhibition therapy in ischemic brain damage in a rat cerebral thrombosis model. Brain research 20080208
Contraction of tubulointerstitial fibrosis tissue in diabetic nephropathy, as demonstrated in an in vitro fibrosis model. Virchows Archiv : an international journal of pathology 20071101
The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation. Vascular health and risk management 20071001
Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons. Brain research 20070618
[Regulatory effects of RhoGTPase on transition of liver sinusoidal capillarization: experiment with mice of schistosomal hepatic fibrosis]. Zhonghua yi xue za zhi 20070612
Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20070501
Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats. Journal of cardiovascular pharmacology 20070201
Wide therapeutic time window for fasudil neuroprotection against ischemia-induced delayed neuronal death in gerbils. Brain research 20070112
Different migration of vascular smooth muscle cells from human coronary artery bypass vessels. Role of Rho/ROCK pathway. Journal of vascular research 20070101
Sustained elevation of serum cortisol level causes sensitization of coronary vasoconstricting responses in pigs in vivo: a possible link between stress and coronary vasospasm. Circulation research 20060929
8-Isoprostane-induced endothelin-1 production by infant rat pulmonary artery smooth muscle cells is mediated by Rho-kinase. Free radical biology & medicine 20060915
Long-term inhibition of Rho kinase suppresses intimal thickening in autologous vein grafts in rabbits. Journal of vascular surgery 20060601
Determination of the enantiomeric excess of an M3 antagonist drug substance by chemometric analysis of the IR spectra of different guest-host complexes. Chirality 20060515
Critical role of the Rho-kinase pathway in TGF-beta2-dependent collagen gel contraction by retinal pigment epithelial cells. Experimental eye research 20060501
The structure of dimeric ROCK I reveals the mechanism for ligand selectivity. The Journal of biological chemistry 20060106
Rho-kinase as a molecular target for insulin resistance and hypertension. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20060101
Cardioprotective effect of hydroxyfasudil as a specific Rho-kinase inhibitor, on ischemia-reperfusion injury in canine coronary microvessels in vivo. Clinical hemorheology and microcirculation 20060101
Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway. Cardiovascular research 20051201
Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial. Journal of the neurological sciences 20051115
Inhibition of rho-kinase by hydroxyfasudil prevents vasopressin-induced myocardial ischemia in Donryu rats by attenuating coronary vasoconstriction. Pharmacology 20051101
Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke 20051001
Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells. Circulation 20050621
Age-related differences in vasoconstrictor responses to isoprostanes in piglet pulmonary and mesenteric vascular smooth muscle. Pediatric research 20050601
Beneficial effect of hydroxyfasudil, a specific Rho-kinase inhibitor, on ischemia/reperfusion injury in canine coronary microcirculation in vivo. Journal of the American College of Cardiology 20050215
Prostacyclin does not inhibit rho-kinase: an implication for the treatment of pulmonary hypertension. Journal of cardiovascular pharmacology 20050201
Effects of hydroxyfasudil administered to the nucleus tractus solitarii on blood pressure and heart rate in spontaneously hypertensive rats. Clinical and experimental hypertension (New York, N.Y. : 1993) 20050101
Pharmacological reversal of endothelin-1 mediated constriction of the spiral modiolar artery: a potential new treatment for sudden sensorineural hearing loss. BMC ear, nose, and throat disorders 20050101
Chronologic changes of fasudil hydrochloride and hydroxyfasudil in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 20050101
The involvement of the rho-kinase pathway and its regulation in cytokine-induced collagen gel contraction by hyalocytes. Investigative ophthalmology & visual science 20041101
Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arteriosclerosis, thrombosis, and vascular biology 20041001
Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C. Circulation 20040706
Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice. Circulation 20040511
Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase. Arteriosclerosis, thrombosis, and vascular biology 20040501
Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circulation research 20040220
[Rho-kinase inhibitor]. Nihon rinsho. Japanese journal of clinical medicine 20040201
Long-term treatment with a specific Rho-kinase inhibitor suppresses cardiac allograft vasculopathy in mice. Circulation research 20040109
Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm. Arteriosclerosis, thrombosis, and vascular biology 20031201
Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circulation research 20031017
Essential role of rho kinase in the Ca2+ sensitization of prostaglandin F(2alpha)-induced contraction of rabbit aortae. The Journal of physiology 20030201
Fasudil attenuates interstitial fibrosis in rat kidneys with unilateral ureteral obstruction. European journal of pharmacology 20021129
Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study. Journal of cardiovascular pharmacology 20021101
[Involvement of Rho-kinase in hypertensive vascular disease--a novel therapeutic target in hypertension]. Fukuoka igaku zasshi = Hukuoka acta medica 20020801
Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 20020702
Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. Journal of cardiovascular pharmacology 20020301
Involvement of rho-kinase in agonists-induced contractions of arteriosclerotic human arteries. Arteriosclerosis, thrombosis, and vascular biology 20020201
Antianginal effects of hydroxyfasudil, a Rho-kinase inhibitor, in a canine model of effort angina. British journal of pharmacology 20011201
Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts. Biochemical and biophysical research communications 20010921
Involvement of Rho-kinase in vascular remodeling caused by long-term inhibition of nitric oxide synthesis in rats. European journal of pharmacology 20010907
Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo. Cardiovascular research 20010701
Hydroxyfasudil, an active metabolite of fasudil hydrochloride, relaxes the rabbit basilar artery by disinhibition of myosin light chain phosphatase. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20010701

© 2019 Angene International Limited. All rights Reserved.